Nicholas Investment Partners LP cut its position in shares of Radius Health, Inc. (NASDAQ:RDUS) by 37.7% during the fourth quarter, Holdings Channel reports. The fund owned 64,043 shares of the biopharmaceutical company’s stock after selling 38,716 shares during the period. Nicholas Investment Partners LP owned about 0.15% of Radius Health worth $2,432,000 at the end of the most recent reporting period.

Other large investors have also recently modified their holdings of the company. Sei Investments Co. boosted its stake in shares of Radius Health by 17.8% in the third quarter. Sei Investments Co. now owns 2,082 shares of the biopharmaceutical company’s stock worth $113,000 after buying an additional 314 shares during the last quarter. Teacher Retirement System of Texas boosted its stake in shares of Radius Health by 21.4% in the second quarter. Teacher Retirement System of Texas now owns 4,169 shares of the biopharmaceutical company’s stock worth $153,000 after buying an additional 736 shares during the last quarter. FNY Partners Fund LP purchased a new stake in shares of Radius Health during the fourth quarter worth $160,000. DIAM Co. Ltd. purchased a new stake in shares of Radius Health during the third quarter worth $170,000. Finally, Russell Investments Group Ltd. purchased a new stake in shares of Radius Health during the fourth quarter worth $197,000. 95.84% of the stock is owned by institutional investors and hedge funds.

Institutional Ownership by Quarter for Radius Health (NASDAQ:RDUS)

Radius Health, Inc. (NASDAQ:RDUS) traded down 0.22% on Friday, reaching $45.06. The company had a trading volume of 58,823 shares. The stock’s market capitalization is $1.94 billion. Radius Health, Inc. has a 12 month low of $24.76 and a 12 month high of $59.88. The firm has a 50-day moving average of $42.95 and a 200-day moving average of $48.89.

“Nicholas Investment Partners LP Cuts Position in Radius Health, Inc. (RDUS)” was published by Watch List News and is the property of of Watch List News. If you are accessing this story on another domain, it was stolen and republished in violation of U.S. & international copyright law. The original version of this story can be accessed at http://www.watchlistnews.com/nicholas-investment-partners-lp-cuts-position-in-radius-health-inc-rdus/1122451.html.

A number of equities research analysts have recently weighed in on RDUS shares. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $70.00 price objective on shares of Radius Health in a research note on Thursday, November 3rd. Canaccord Genuity reissued a “buy” rating and set a $85.00 target price on shares of Radius Health in a research note on Wednesday, December 21st. Finally, Zacks Investment Research cut Radius Health from a “hold” rating to a “sell” rating in a research note on Wednesday, January 4th. Two research analysts have rated the stock with a sell rating, two have given a hold rating and five have assigned a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $57.57.

Radius Health Company Profile

Radius Health, Inc is a biopharmaceutical company focused on developing therapeutics in the areas of osteoporosis, oncology and endocrine diseases. Its product candidate, the investigational drug abaloparatide for subcutaneous injection, has completed Phase III development for use in the reduction of fracture risk in postmenopausal women with osteoporosis.

5 Day Chart for NASDAQ:RDUS

Want to see what other hedge funds are holding RDUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Radius Health, Inc. (NASDAQ:RDUS).

Receive News & Ratings for Radius Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Radius Health Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.